Professor Colin Dayan



Prosiectau fel Prif Ymchwiliwr
null null 2 o 7 null null

Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED) trial - Cyllidwr:University of Bristol (01.10.2014 - 30.06.2015)
NAMIT - Novel immunotherapies for type 1 diabetes - Cyllidwr:Commission of the European Communities (01.08.2010 - 30.04.2015)
Regulatory CD8 cells in type 1 diabetes - Cyllidwr:Society of Endocrinology (20.06.2011 - 14.08.2011)
Microneedle arrays to deliver antigen specific immunotherapy - Cyllidwr:Juvenile Diabetic Research Foundation (01.10.2014 - 31.12.2019)


Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 3 null null

Microneedle delivery of antigen-specific immunotherapy for type 1 diabetes - Cyllidwr:Engineering and Physical Sciences Research Council (01.10.2014 - 30.09.2018)
B cells in newly diagnosed type 1 diabetes - Cyllidwr:Diabetes UK (01.03.2012 - 31.07.2016)
Peptide-HLA multimers as biomarkers of autoimmune disease - Cyllidwr:Wellcome Trust (01.07.2012 - 31.07.2014)

Diweddarwyd y tro diwethaf ar 2020-02-08 am 04:07

Rhannu dolen